In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...
Sept. 17, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced the launch of Vertex for ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...
According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.15%, ...
KING OF PRUSSIA, Pa., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology ...
Here are three reasons to buy Vertex Pharmaceuticals stock like there's no tomorrow. I can't think of many companies with a more resilient business than Vertex. The drugmaker should be able to ...
HOUSTON, TX – Vertex Energy (NASDAQ:VTNR) Inc., a petroleum refining company, has received a notification from The Nasdaq Stock Market LLC indicating non-compliance with the exchange's minimum ...